Patent · US Active

Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof

US9597292B2 · kind B2 · utility

0Cited by

42References

4Claims

0Family size

Assignee

XENOPORT, INC. · US

Inventors

Sami Karaborni · Cupertino, US
Sarina Grace Harris Ma · Santa Clara, US
Chen Mao · Shanghai, CN
Ching Wah Chong · Fremont, US
Peter Robert Prinz Freed · Linglestown, US
Mesut Ciper · Oelde, DE
Stefanie Krenzlin · Munster, DE
David Juergen Wustrow · Ann Arbor, US
Peter A. Virsik · Portola Valley, US

Key dates

Filing date	Aug 22, 2013
Grant date	Mar 21, 2017
Priority date	—
Expiry date	Jul 17, 2034

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Improved oral dosage forms of methyl hydrogen fumarate and prodrugs thereof are disclosed. Methods of treating diseases such as multiple sclerosis and psoriasis using such dosage forms are also disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.